Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant

BACKGROUND: There is a lack of data regarding how the Delta variant of coronavirus disease 2019 (COVID-19) has impacted the effectiveness of the BNT162b2 (Pfizer–BioNTech), mRNA-1273 (Moderna), and Ad26.COV2.S (Johnson & Johnson–Janssen) vaccines at preventing severe acute respiratory syndrome c...

Descripción completa

Detalles Bibliográficos
Autores principales: Risk, Malcolm, Shen, Chen, Hayek, Salim S, Holevinski, Lynn, Schiopu, Elena, Freed, Gary, Akin, Cem, Zhao, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047165/
https://www.ncbi.nlm.nih.gov/pubmed/35137006
http://dx.doi.org/10.1093/cid/ciac106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047165/
https://www.ncbi.nlm.nih.gov/pubmed/35137006
http://dx.doi.org/10.1093/cid/ciac106

Ejemplares similares